{"id":559650,"date":"2026-06-12T08:00:00","date_gmt":"2026-06-12T06:00:00","guid":{"rendered":"https:\/\/medizinonline.com\/inhibidores-orales-de-tyk-altamente-selectivos-en-fase-iii\/"},"modified":"2026-06-18T17:17:34","modified_gmt":"2026-06-18T15:17:34","slug":"inhibidores-orales-de-tyk-altamente-selectivos-en-fase-iii","status":"publish","type":"post","link":"https:\/\/medizinonline.com\/es\/inhibidores-orales-de-tyk-altamente-selectivos-en-fase-iii\/","title":{"rendered":"Inhibidores orales de TYK altamente selectivos en fase III"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong>El envudeucitinib y el zasocitinib son inhibidores alost\u00e9ricos orales de la tirosina quinasa 2 (TYK2) que actualmente se est\u00e1n evaluando en ensayos cl\u00ednicos para el tratamiento de la psoriasis en placas. Los resultados provisionales presentados en el marco de las sesiones de \u00abLate-Breaking Research\u00bb del congreso anual de este a\u00f1o de <em>la Academia Americana de Dermatolog\u00eda<\/em> (AAD) llaman la atenci\u00f3n. Cabe destacar tambi\u00e9n su favorable perfil de seguridad, lo que, junto con la v\u00eda de administraci\u00f3n oral, supone una gran ventaja en cuanto a la comodidad.    <\/strong><\/p>\n\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/es\/mi-cuenta\/paquetes\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">\u00bfYa eres miembro? <a href=\"https:\/\/medizinonline.com\/es\/conectarse\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Fes%2Finhibidores-orales-de-tyk-altamente-selectivos-en-fase-iii%2F\">Accede aqu\u00ed<\/a><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>El envudeucitinib y el zasocitinib son inhibidores alost\u00e9ricos orales de la tirosina quinasa 2 (TYK2) que actualmente se est\u00e1n evaluando en ensayos cl\u00ednicos para el tratamiento de la psoriasis en&#8230;&hellip;... <\/p>\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/es\/mi-cuenta\/paquetes\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">\u00bfYa eres miembro? <a href=\"https:\/\/medizinonline.com\/es\/conectarse\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Fes%2Finhibidores-orales-de-tyk-altamente-selectivos-en-fase-iii%2F\">Accede aqu\u00ed<\/a><\/div><\/div><\/div>","protected":false},"author":7,"featured_media":559654,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":"","cat_1_feature_home_top":false,"cat_2_editor_pick":false,"csco_eyebrow_text":"Investigaci\u00f3n sobre la psoriasis: \u00bfqu\u00e9 proyectos hay en fase de desarrollo?  ","footnotes":""},"category":[11552,11298,11310,11483,11475,11408,11451],"tags":[21775,95040,95046,95045,95049,95042,95055,95050,13983,95053,95054],"powerkit_post_featured":[],"class_list":["post-559650","post","type-post","status-publish","format-standard","has-post-thumbnail","category-rx-es","category-alergologia-e-inmunologia-clinica","category-dermatologia-y-venereologia","category-el-congreso-informa","category-estudios","category-farmacologia-y-toxicologia","category-reumatologia","tag-aad-es","tag-academia-americana-de-dermatologia","tag-comodidad","tag-conducto","tag-envudeucitinib","tag-inhibidores-de-la-tyk","tag-latitude-3002","tag-latitude-pso-3001","tag-psoriasis-es-2","tag-resultados-provisionales","tag-zasocitinib","pmpro-level-required","pmpro-level-1","pmpro-no-access"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-06-29 00:54:29","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"wpml_current_locale":"es_ES","wpml_translations":[],"_links":{"self":[{"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/posts\/559650","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/comments?post=559650"}],"version-history":[{"count":1,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/posts\/559650\/revisions"}],"predecessor-version":[{"id":559655,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/posts\/559650\/revisions\/559655"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/media\/559654"}],"wp:attachment":[{"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/media?parent=559650"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/category?post=559650"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/tags?post=559650"},{"taxonomy":"powerkit_post_featured","embeddable":true,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/powerkit_post_featured?post=559650"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}